Alfredo Cabrera-Socorro
Overview
Explore the profile of Alfredo Cabrera-Socorro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puerta R, Cano A, Garcia-Gonzalez P, Garcia-Gutierrez F, Capdevila M, de Rojas I, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796148
High-throughput proteomic platforms are crucial to identify novel Alzheimer's disease (AD) biomarkers and pathways. In this study, we evaluated the reproducibility and reliability of aptamer-based (SomaScan 7k) and antibody-based (Olink...
2.
Morato X, Puerta R, Cano A, Orellana A, de Rojas I, Capdevila M, et al.
Brain Behav Immun Health
. 2024 Dec;
42:100899.
PMID: 39640195
Despite the central role attributed to neuroinflammation in the etiology and pathobiology of Alzheimer's disease (AD), the direct link between levels of inflammatory mediators in blood and cerebrospinal fluid (CSF)...
3.
Ahmad S, Yang W, Orellana A, Frolich L, de Rojas I, Cano A, et al.
Alzheimers Res Ther
. 2024 Jul;
16(1):171.
PMID: 39080778
Background: Isoprostanes and prostaglandins are biomarkers for oxidative stress and inflammation. Their role in Alzheimer's disease (AD) pathophysiology is yet unknown. In the current study, we aim to identify the...
4.
Haidar M, Schmid B, Ruiz A, Ebneth A, Cabrera-Socorro A
Stem Cell Res
. 2024 May;
77:103414.
PMID: 38703665
Late-onset Alzheimer's disease (AD) has become the paradigm of a non-mendelian complex neurodegenerative disease, for which a major genetic determinant is known, the APOE locus. A rare APOE variant named...
5.
He K, Khramtsova E, Cabrera-Socorro A, Zhang Y, Li S, Sarver B, et al.
Mol Neurodegener
. 2023 Nov;
18(1):92.
PMID: 38017580
No abstract available.
6.
Kwok C, Sebastien I, Hariharan K, Meiser I, Wihan J, Altmaier S, et al.
Reprod Toxicol
. 2022 May;
112:23-35.
PMID: 35595152
Induced pluripotent stem cell (iPSC) technology enabled the production of pluripotent stem cell lines from somatic cells from a range of known genetic backgrounds. Their ability to differentiate and generate...
7.
EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines
Steeg R, Mueller S, Mah N, Holst B, Cabrera-Socorro A, Stacey G, et al.
Stem Cell Reports
. 2021 Aug;
16(8):1853-1867.
PMID: 34380020
Disease-relevant human induced pluripotent stem cells (iPSCs) are generated worldwide for research purposes; however, without robust and practical ethical, legal, and quality standards, there is a high risk that their...
8.
Shih P, Kreir M, Kumar D, Seibt F, Pestana F, Schmid B, et al.
Stem Cell Res
. 2021 Jul;
54:102386.
PMID: 34229210
Neurogenin 2 encodes a neural-specific transcription factor (NGN2) able to drive neuronal fate on somatic and stem cells. NGN2 is expressed in neural progenitors within the developing central and peripheral...
9.
Neyrinck K, Van Den Daele J, Vervliet T, De Smedt J, Wierda K, Nijs M, et al.
Stem Cell Rev Rep
. 2021 May;
17(5):1855-1873.
PMID: 33982246
Astrocytes, the main supportive cell type of the brain, show functional impairments upon ageing and in a broad spectrum of neurological disorders. Limited access to human astroglia for pre-clinical studies...
10.
Madrid L, Moreno-Grau S, Ahmad S, Gonzalez-Perez A, de Rojas I, Xia R, et al.
Aging (Albany NY)
. 2021 Apr;
13(7):9277-9329.
PMID: 33846280
Alzheimer's disease (AD) is the most common form of dementia, currently affecting 35 million people worldwide. Apolipoprotein E (APOE) ε4 allele is the major risk factor for sporadic, late-onset AD...